Moberg Pharma AB (publ) Cash Flow Quality Index
Moberg Pharma AB (publ) cash flow quality index. Moberg Pharma AB (publ) (MOB) has a Cash Flow Quality Index of -0.70x as of September 2019. Operating cash flow of Skr-29.30 Million is below net income of Skr41.76 Million, suggesting accrual-heavy earnings not yet converted to cash. See MOB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Moberg Pharma AB (publ) (2012–2021)
Cash flow quality index of Moberg Pharma AB (publ) from 2012 to 2021. Historical Cash Flow Quality Index for Moberg Pharma AB (publ) across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Moberg Pharma AB (publ) (MOB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Moberg Pharma AB (publ) Cash Flow Quality Index by Year (2012–2021)
Moberg Pharma AB (publ) cash flow quality index by year from 2012 to 2021. Year-by-year earnings quality comparison for Moberg Pharma AB (publ). For the full cash flow conversion analysis, see cash efficiency ratio of Moberg Pharma AB (publ).
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.04x | Skr-15.30 Million | Skr7.49 Million | ▼ -1134.5% |
| 2019 | 0.20x | Skr3.95 Million | Skr20.02 Million | ▼ -82.7% |
| 2018 | 1.14x | Skr73.89 Million | Skr64.82 Million | ▲ +8.2% |
| 2017 | 1.05x | Skr53.82 Million | Skr51.07 Million | ▲ +465.2% |
| 2016 | -0.29x | Skr-17.94 Million | Skr62.17 Million | ▼ -133.1% |
| 2015 | 0.87x | Skr30.72 Million | Skr35.18 Million | ▼ -6.9% |
| 2014 | 0.94x | Skr16.16 Million | Skr17.23 Million | ▲ +24.7% |
| 2012 | 0.75x | Skr9.48 Million | Skr12.59 Million | — |